The "right" control group for acupuncture studies will depend on the precise question being asked. In 1997, the NIH Consensus Development Conference asked two broad questions regarding acupuncture that have implications for selecting appropriate comparison groups. These questions were: (1) What is the efficacy of acupuncture compared with placebo or sham acupuncture? and (2) What is the place of acupuncture in comparison or in combination with other interventions?
The "right" control group for acupuncture studies will depend on the precise question being asked. In 1997, the NIH Consensus Development Conference asked two broad questions regarding acupuncture that have implications for selecting appropriate comparison groups. These questions were: (1) What is the efficacy of acupuncture compared with placebo or sham acupuncture? and (2) What is the place of acupuncture in comparison or in combination with other interventions?
Answering the first question examines the issue of whether or not acupuncture works by looking for the "specific effects" of acupuncture, which is often taken to mean the effects of needling. While such an approach is typically straightforward in a study of medications or herbs, there are a number of issues that make it more challenging to apply to acupuncture.
In any treatment, there are a variety of factors that could account for improvement in symptoms, including the natural history of the condition, extra attention, enthusiasm of the provider, positive expectations of the patient, the "meaning response," physiological effects of needling anywhere, and physiological effects of needling in the "proper" locations. Typically, a placebo intervention would control for natural history, extra attention, enthusiasm of the provider, positive expectations of the patient, and the "meaning response" and would look exactly like the treatment.
While a variety of controls, including sham laser, sham TENS [transcutaneous electrical nerve stimulation], noninsertion of needles, and "placebo" needles, have been used, ostensibly to control for these effects, each of them has its limitations. For example, sham laser and sham TENS do not look like needles, whereas noninsertion of needles (e.g., poking the blunt end on the skin) or using "placebo" needles, which retract into the handle of the needle, may not be inert treatments.
Insertive sham controls have been controversial because needle insertion, regardless of location, may exert physiological effects. Nonetheless, to control for needle-related factors, such as location and/or stimulation and/or depth of insertion, studies have needled "inappropriate" points, inserted needles superficially, and/or failed to stimulate the needles. Some authors have suggested that a sham control should include superficial needling of "inappropriate" points without needle stimulation.
As a result of controversies over acupuncture research methods identified at the Consensus Development Conference, the NIH [National Institutes of Health] 1 issued a Program Announcement requesting applications for pilot studies to address methodological issues in acupuncture research.
Six studies were funded, and five of those dealt with defining appropriate control groups. A study of depression in pregnant women found that "specific" acupuncture was better than "nonspecific" acupuncture and a massage attention control. 2 Among patients with carpal tunnel syndrome, "specific" acupuncture was no better than "irrelevant meridian" or nonchannel, nonpoint acupuncture. 3 Two studies of fibromyalgia failed to find acupuncture better than the control conditions, which were nonchannel, nonpoint needling with or without stimulation in one study 4 and either acupuncture for another condition, nonchannel, nonpoint acupuncture, or simulated acupuncture in the other study. 5 In the last study comparing two kinds of "real" acupuncture with irrelevant point acupuncture, simulated (noninsertive) acupuncture, or a self-care book, acupuncture was better than the self-care book, there was little difference between any needling group, and the noninsertive simulated acupuncture treatment was intermediate. 6 Collectively, these studies suggest that needling location and stimulation may not be critical for pain conditions, but show conflicting results regarding the value of insertion itself.
The general conclusion was that for placebo-controlled trials, a three-arm design should be considered to anchor the findings in clinical relevance and that fMRI [functional magnetic resonance imaging] studies may shed light on the optimal "placebo" control groups for clinical trials.
The second question looks at the practical issue of where acupuncture is a useful intervention in current clinical practice, while ignoring the question of what components might contribute to acupuncture's effectiveness. In the pragmatic trials undertaken to answer this question, the appropriate comparison group would be another treatment for the condition under study. In the UK [United Kingdom], two large pragmatic trials have compared acupuncture to usual care and found acupuncture superior for back pain and for headache. In the US [United States], one large pragmatic trial compared acupuncture with massage and with self-care materials and found massage superior to acupuncture. ered, well-designed controlled acupuncture trials. Almost 10 years later, the evidence for the efficacy of acupuncture remains inconclusive or contradictory for a large number of conditions. This may be due at least in part, to methodological challenges specific to conducting clinical trials of multivariate, complex interventions such as acupuncture. One of those challenges involves the selection of appropriate controls.
In order to evaluate whether invasive sham controls have produced equivocal or contradictory results more often than noninvasive controls in clinical trials of acupuncture, we are currently conducting a critical review of literature to include all randomized controlled trials of acupuncture conducted in 1997-2006. Our purpose is to identify those studies that have used acupuncture-like sham controls, either invasive or noninvasive. Invasive sham controls are defined by the use of devices that penetrate the skin and that aim at controlling the selection of points (i.e., nonspecific/sham versus acupoints), the type of stimulation (i.e., shallow versus standard needling) or both. So far, we have identified a total of 107 randomized controlled trials of acupuncture that used an acupuncture-like sham control.
During 1997-2004, 43 studies met this criterion (10 studies with sample size 50-99; 7 studies Ͼ 100). Thirteen used a traditionally based style of acupuncture (TBSA), all of which used TCM [Traditional Chinese Medicine], and one of which also included Japanese acupuncture. Six (6) used individualized treatments, 1 combined electroacupuncture with manual stimulation, and 1 combined acupuncture with herbs. More than half (59%, 10 studies) found acupuncture to be effective over the sham-controlled intervention (5, n ϭ 100 or more); 5 studies focused on pain-related conditions; 90% of these studies used an invasive sham control.
For studies conducted between January 2005 and through April 2006, we identified 29 randomized controlled trials of acupuncture; 14 met our criteria (five studies n ϭ 50-99; 9 studies n ϭ 100 or more). Eleven (11) studies used a TBSA (10 used TCM; 1 used Korean); 6 studies used individualized treatment, and all used manual stimulation, noncombined acupuncture with herbs. Of all 14 studies, only 1 study found acupuncture to be significantly more effective than the sham-control intervention 2 in the primary outcome, and only 1 study found [that] acupuncture outperformed the sham controlled in secondary outcomes. 3 Ninety percent of those studies used an invasive sham control. Six of seven studies (n ϭ 100 or more), which found acupuncture to be no more effective than a sham control, aimed at evaluating acupuncture in the treatment of pain-related conditions.
Although these results are very preliminary, it is interesting to note that most recent large randomized controlled trials of acupuncture (n ϭ 100 or more) have used an invasive sham control and most have failed to find a significant difference between acupuncture and an acupuncture-like sham intervention.
In order to design an appropriate intervention that controls for the specific effects of acupuncture, it is necessary to first understand the mechanism by which acupuncture works. Appropriate controls in clinical trials of acupuncture need to derive from a clear understanding of the mechanism of action of acupuncture (e.g., the needling process, and the specificity of acupuncture points). Acupuncture sham controls must be inert as defined by the Chinese Medicine explanatory model; invasive sham controls may be an inadequate control for clinical trials of acupuncture.
The processing of acupuncture stimuli by the brain can be encapsulated by a combination of expectation (prior), sensation (during), and contextualization (post). While sham forms of acupuncture have been designed to control for supposed "nonspecific" effects, these controls also influence expectation, sensation, and contextualization. Thus, there is potential overlap in effects of both sham and verum acupuncture.
Furthermore, as the "specific" mechanisms of verum acupuncture have not been unequivocally identified, designing a sham control that stimulates only nonspecific effects has been difficult. Top-down descending pain modulation networks may be stimulated to a variable degree by both verum and sham acupuncture. Neuroimaging is a potential approach to disentangle these effects, as there may exist a specific brain response attributable to verum compared with sham acupuncture interventions.
Neuroimaging (e.g., fMRI [functional magnetic resonance imaging], PET [positron emission tomography], etc.) noninvasively explores brain activity in humans in response to various stimuli, and past studies have provided important clues regarding how the brain responds to different sham acupuncture stimuli. Furthermore, neuroimaging can demonstrate potential differences between patient populations and healthy subjects in their response to both sham and verum acupuncture.
Most previous acupuncture neuroimaging studies have been performed on healthy subjects. Controls in these studies have included insertive nonacupoint stimulation, such as minimal electro-acupuncture and superficial pricking. Additionally, noninsertive acupoint stimulation has been performed with "placebo-needles" 1 or, since the fMRI environment precludes visual feedback, with von Frey monofilaments. [2] [3] [4] These procedures attempt to control for somatosensory and/or cognitive aspects of acupuncture.
Insertive, nonacupoint stimulation has been explored with fMRI. Minimally sensible, shallow-insertion electroacupuncture was found to produce fMRI activation in both somatosensory (thalamus) and cognitive (dorsolateral prefrontal cortex, DLPFC) brain regions. 5 Wu et al. 6 also found that superficial pricking with an acupuncture needle at a nonacupoint produces activity not only in somatosensory (thalamus, SI, SII) and cognitive (DLPFC) brain regions, but also in affective/motivational pain processing areas (anterior cingulate cortex, ACC).
Noninsertive sham acupuncture at an acupoint has been explored with both PET and fMRI. Pariente et al. used PET in osteoarthritis patients to compare LI-4 [acupuncture point Large Intestine-4] stimulation with verum acupuncture, Streitberger-needle, or overt placebo. 7 They found that placebo-needle stimulation produced greater activation than overt placebo in both cognitive (DLPFC) and pain-modulatory (rostral ACC, rACC) brain regions. Our group has used fMRI to explore differences in verum and sham acupuncture processing in chronic pain (carpal tunnel syndrome, CTS) patients compared with healthy controls (HC). 8 Sham acupuncture was delivered with von Frey monofilament to LI-4, and subjects were instructed to expect "different forms" of acupuncture. A conjunction analysis found that both CTS and HC responded to sham acupuncture with activation in somatosensory brain regions (thalamus, SII, left posterior insula) and deactivation in the hippocampus. However, CTS patients demonstrated greater fMRI activation than HC not only in somatosensory brain regions (SI), but also in important cognitive (DLPFC) and affective/motivational pain modulatory areas (rACC/ventromedial prefrontal cortex, VMPFC).
The ACC, which has been implicated in several sham acupuncture neuroimaging studies, may be an especially pertinent brain region, because it has been activated in a host of placebo analgesia studies. The pregenual/subgenual ACC is an area of the brain rich in endogenous opioid receptors and is intimately interconnected with other brain regions that process pain, reward, autonomic, and neuroendocrine functions. Zubieta et al. 9 used PET to localize placebo drug infusion-induced -opioid neurotransmission to this ACC subregion. Furthermore, placebo analgesia using the Streitberger needle was found to also be localized to a similar rACC region in a recent fMRI study. 10 Moreover, brain activity in the ACC can be used as real-time biofeedback to modulate pain levels in patients with chronic pain. 11 Also, fMRI activity in a more dorsal ACC subregion has been observed during pain empathy in subjects who were alternately subjected to a pain stimulus or observed their loved one experiencing the same pain stimulus. 12 Ultimately, the mind is a powerful modulator of pain and other subjective clinical or subclinical symptoms. Most forms of sham acupuncture have biophysical effects and can impact expectation, sensation, and contextualization. Thus, brain processing in affective and cognitive brain regions responsible for top-down descending analgesic control may help explain the powerful placebo effects observed in several recent large acupuncture randomized controlled trials. In choosing appropriate controls, it may be best to stay away from more invasive sham procedures, which have been shown to affect pain processing regions. Furthermore, chronic pain patients may process even noninvasive sham acupuncture to a greater degree in affective/cognitive brain regions compared with healthy controls. Hence, the caveat above may be even more pertinent for trials with clinical pain populations. There is now a large body of published acupuncture studies, many of them well-designed, but results are inconclusive. One large clinical trial on the effect of acupuncture on osteoarthritis of the knee showed that traditional Chinese acupuncture is superior to sham acupuncture control in reducing pain and improving function. 1 On the other hand, another clinical trial on the same condition showed no significant difference between acupuncture and control, 2 perhaps due largely to the challenge of devising invasive sham acupuncture controls. However, animal studies that explore acupuncture mechanisms often show positive results compared to sham control. Animal studies and clinical trials present different challenges. In human pain studies, the placebo effect plays an important role in treatment response and may be triggered by the patient's psychology or prior knowledge of the intervention. Furthermore, patients with different diseases and pain conditions may respond differently to acupuncture. Challenges in animal studies include nonspecific effects due to experimental procedures (e.g., from restraints or noxious stimuli that elicit spinal reflex and transient reactions, lack of clarity on the relevance of animal acupoints to those in humans, and variations in severity of disease among models). Nevertheless, animal studies yield much information on such issues as "dosage" and point specificity.
Animal studies show that acupuncture effects are dosedependent, where "dosage" includes the intensity of electroacupuncture (EA) at acupoints 3 and the amount of therapeutic material injected into a point. 4, 5 For example, Kim et al. 4 showed in a rat model that bee venom at ST36 [Stomach 36] suppressed formalin-induced inflammation in a dose-dependent manner. Another laboratory reported that an Ephedra sinica extract injected into ST36 produced a dosedependent inhibition of TNF-␣ [tumor necrosis factor-␣] and COX-2 [cyclooxygenase-2] expression in PMA/LPS*-induced inflammation. 5 Additional animal studies have shown that acupuncture effects are point specific. Koo et al. 6 reported that treatment at SI6 [Small Intestine 6] produced significant analgesia on a rat model of ankle sprain pain compared to treatment at a nearby point. Lee and Beitz 7 showed that EA on normal rats at ST36 activated brainstem regions but had no such effect at the hamstring muscle. Lao et al. 3 reported similar results in a persistent inflammatory rat model. Tjen-A-Looi et al. 8 In a rat study investigating the effect of acupuncture on ethanol withdrawal, Zhao et al. 9 reported that acupuncture at H7 [Heart 7], not P6 [Pericardium 6] or the tail, significantly prevented release of dopamine during the ethanol challenge.
The high degree of point specificity for given conditions in animal studies contrasts to human clinical trial results showing similar effects from sham treatment at nonspecific acupoints and intended acupuncture intervention.
This difference may be due to several factors: 1. Animal studies use naïve animals with no prior exposure to acupuncture.
2. The controllable pathology and severity of the model make it possible to configure conditions adequate to test acupuncture effects. For example, an adequate dosage of an inflammatory agent will produce a model that allows researchers to differentiate acupuncture effects from those of sham treatment. 10 3. Experimental animals are often genetically homogeneous, with little variation from individual to individual, which narrows the standard deviation in statistical analysis.
4. Animal studies also may be underreporting animals that fail to show the desired effect, as the intention-to-treat concept has not been widely applied to statistical analysis in animal studies. However, this may be justifiable as, unlike human clinical trials, the major, if not sole, purpose of animal studies is to explore mechanisms of action. A reliable animal model capable of reproducible results is critical for animal basic science.
Translational Research Strategy for Developing
Objective Outcome Measures Reflecting Traditional Chinese Medicine
Departments of Neurology, Orthopaedics and Rehabilitation, University of Vermont, Burlington, VT
Testing the effectiveness of a treatment is difficult if one does not understand the pathophysiology of the condition being treated. For example, testing the effect of a new drug for diabetes would be very difficult if one were measuring how the patient feels, instead of measuring the blood sugar. In Traditional Chinese Medicine [TCM], the condition being treated may be a syndrome such as "Spleen Qi deficiency" or "Liver Qi stagnation," but the pathophysiological basis underlying these syndromes remains unknown (Spleen Qi deficiency is associated with symptoms such as loose stools, poor muscle tone, and prolapse of tissues, while Liver Qi stagnation is associated with oppression in [the] chest, abdomen, and throat, and emotional frustration and anger).
Let us consider a hypothetical clinical trial of acupuncture for myofascial pain. Increasingly, investigators conducting such trials are placing patients into subgroups according to TCM diagnoses for the purpose of treatment selection.
Subjects recruited to participate in this trial thus may include some with Spleen Qi deficiency and some with Liver Qi stagnation. So far, however, the outcome measures used in such trials are still related to the Western diagnosis (i.e., myofascial pain) rather than the TCM condition. If specific pathological abnormalities related to myofascial pain and associated with TCM syndromes could be identified, morespecific clinical trials could be performed using objective outcome measures that reflect not just pain, but also TCM.
A translational research strategy aimed at developing objective outcome measures that reflect TCM, therefore, can be outlined as follows:
First, identify physiological processes related to Spleen and Liver function that may be relevant to myofascial pain (e.g., maintenance of normal tissue composition, structure, viscoelasticity, and water content). Second, compare tissue structure, viscoelasticity, etc. . . . in groups of patients with Spleen Qi deficiency to those with Liver Qi stagnation. Finally, conduct a clinical trial of acupuncture in patients with chronic myofascial pain and Spleen Qi deficiency or Liver Qi stagnation, using these tissue measurements as outcome measures (in addition to subjective "whole person" outcomes).
Such a translational approach "from the ground up" first seeks a more thorough understanding of the condition being studied, then moves on to use this basic knowledge to objectively measure efficacy. Although this type of approach is likely to take much time, the rewards at the end of the road may be well worth the effort.
Do Sham-Controlled Trials Underevaluate the Real-World Effectiveness of Acupuncture?
Richard Hammerschlag, Ph.D.
Research Department, Oregon College of Oriental Medicine, Portland, OR
Arguably, a case can be made that inclusion of a sham acupuncture arm in a randomized controlled trial (RCT) will lead to an underestimation of treatment efficacy. This seeming anomaly, inherent in the acupuncture versus sham acupuncture research design, may be a net result of a decreased benefit to the treatment group, relative to the putative benefit of the same acupuncture treatment provided in an unblinded manner, and an increased benefit to the sham (control) group, relative to the benefit of a placebo response alone. Reduced benefit to the treatment group may be an unappreciated confounder in all placebo or sham-controlled trials if findings from sequential trials, in which the same dose of a new opioid analgesic was compared first to a placebo and then to a standard-care analgesic, are generalizable. 1 The explanation offered as to why the new drug was found more effective when compared with standard care than when compared with placebo was based on presumptive, consent form-induced expectations. Participants learned during consenting that they stood a 50% chance of receiving active treatment in the first trial, but that either arm in the second trial would bring analgesic benefit.
Enhanced benefits from sham acupuncture, which are especially likely from invasive sham needling (even at nonacupuncture point sites), have been suggested to result from locally induced changes in microcirculation, immune system responses, and even nonspecific pain modulation mechanisms. 2 More generally, because of the paucity of our understanding of how acupuncture works (e.g., what the needle stimulates, what signals are generated, and how homeostatic regulation is triggered), sham needling may inadvertently activate (albeit less robustly) the same regulatory mechanisms that are triggered by needling at acupuncture points. 3 Just as an appropriate sham should mimic all aspects of practitioner delivery of treatment, it should not mimic any aspect of the physiological action of the treatment. Even noninvasive sham procedures, such as tapping an empty needle guide tube on the skin surface, may trigger physiological regulatory responses, especially if the tube is tapped at acupuncture points. 4 Thus, to the extent that design features of sham-controlled RCTs may reduce the effects of the true acupuncture treatment as well as enhance the effects of the sham treatment, such trials are prone to type 2 (false-negative) errors. It follows that such trials may not adequately assess the effectiveness of real-world acupuncture treatments. One suggestion that meets this concern is for future sham-controlled RCTs to randomize participants to three arms: acupuncture and sham acupuncture (as in the currently accepted manner that purports to ensure blinding) and a third arm in which patients receive the same acupuncture protocol and are told they are receiving real treatment. This approach allows both explanatory (blinded) and pragmatic (unblinded) assessments of acupuncture and may reveal whether acupuncture effectiveness is being systematically underevaluated in the current design of sham-controlled RCTs. Ronald Glick, M.D., (University of Pittsburgh): I'm involved in acupuncture research and my observation is that when I use tiny, skinny needles and place the needles superficially in nonacupuncture points, rarely, in less than 100 insertions, does the patient or the subject have anything beyond a very mild sensation of a needle going through the skin. So if de qi is the operative phenomenon, then how does one interpret that observation? Rosa N. Schnyer, Lic.Ac.: De qi is defined in different ways depending on who is interpreting the classic text. In TCM, the practitioner is supposed to feel de qi, and the patient is also supposed to feel de qi. In Japanese acupuncture, as a practitioner, you can perceive de qi just by feeling with the hand that's not your needling hand but the patient does not necessarily have to feel it. So we don't really know that de qi is the defining aspect of acupuncture. It could be that de qi as assessed in TCM denotes a specific effect elicited by stronger needle stimulation, different from that of Japanese acupuncture, which consists of lighter needling stimulation.
ROUNDTABLE DISCUSSION
Since Every speaker thus far has alluded to the importance of psychosocial factors in acupuncture research; however, I don't think that we are actually measuring these factors adequately in large clinical trials of acupuncture. Systematically measuring these variables across prospective studies will allow us to develop either a predictive or an explanatory model to inform the biobehavioral mechanism of acupuncture. Having similar measures across studies would then also allow us to pull the data for future meta-analysis or systematic analysis. Important components such as patient expectation of outcomes, the perceived experience of the de qi, and aspects of the patient/provider relationship can and should be measured.
A second point I would like to make is that with any therapy, whether conventional or complementary, there are responders and nonresponders. As an acupuncturist, I see people who respond really well and people who don't respond at all. Understanding for what type of population acupuncture works will help guide clinical care to provide patients with the right types of therapies. How are we going to address this issue in clinical trial design? In the end, the most clinically important question is not whether acupuncture works better than sham acupuncture; instead it should be for whom and for what conditions does acupuncture-sham or real-work, either through psychosocial factors or via specific needling. This question is for Dr. Langevin. I agree and appreciate your argument that we need to spend more effort in looking at the pathophysiology, the mechanisms of conditions, and markers. But there are many clinical trialists who favor the use of clinical outcomes or patient-oriented outcomes that matter. Objective outcomes are maybe more directly relevant than surrogate measures. For instance, the example that you gave of diabetes, one could not understand the mechanism of the disease itself but look at outcomes, such as hospitalizations or complications, that develop. So I'd like for you to comment on the possibility of either in parallel, or instead of, focusing on mechanisms when those might be difficult to really establish, to look at objective outcomes that are measurable but are not specifically related to the mechanism. Dr. Langevin: I think you put it very well. The most pragmatic way we could look at this is to say: "Does this save health care dollars?" Some of the pragmatic trials are getting at that, looking at the population and comparing people having acupuncture versus people having some other form of health care. You see how many times they have to go to the emergency room or how many MRI scans they need. I think we need to do both, clearly. I think they are both ends of a very long spectrum, and we cannot look only at one end. I totally agree.
Charlotte Paterson, M.R.C., (University of Bristol, United Kingdom): I think what we need to question is this rush into sham acupuncture trials that's happening, and whether this is the right way to go. To do a sham acupuncture trial, as Karen says, is all about deconstruction; deconstructing the therapy into different bits and putting some in some boxes and some in others. But if we believe acupuncture to be a holistic therapy, and certainly its theory base would suggest that it is, then maybe it can't be deconstructed without losing what it's all about. The whole point of a holistic therapy is the synergy and that things relate to each other.
In this vein, I draw upon a lot of qualitative work that I've done interviewing patients who've had acupuncture. Certainly, from their perspective, they describe a lot of [things that are] in actuality about holism. Taking Richard's examples, for example, that what we do with a sham acupuncture trial actually decreases the specific effect of real acupuncture, well I've certainly got a lot of examples of that. For example, in real life, the needling that goes on develops over a long period of time after the initial diagnosis and emergent diagnosis, changing needling according to what the patient says about new illnesses that arrive. It's a whole emergent process, whereas in a strictly experimental acupuncture trial the needling can't be like that.
The other side of sham acupuncture is that it also increases the benefit in the control group. So qualitative research does support this argument and does make us question whether a sham control design is actually appropriate for a holistic therapy.
Richard Hammerschlag, Ph.D.: As a quantitative researcher, I'm always delighted to learn more about the benefits and, in this case, the support from qualitative research.
Dr. Sherman:
Of course, I agree with you. But I also think it would be very interesting, in the process of attempting some amount of deconstruction with its various problems, to actually see what fraction of acupuncture is more or less due to the different pieces that are hypothesized to be part of the healing benefits from acupuncture treatments. I have no idea what the answer is, although I have some thoughts on it and I think that actually would be quite fascinating. You could do a study with even more treatment groups, [such as] probably 10 arms, where you have a lot of these different pieces and actually get some estimates of how relatively important the different pieces are. Holism might turn out to be enormous, or it might turn out to be a relatively small aspect once you actually look at what fraction contributes to different aspects of the final outcome. 
Ms. Schnyer:
We explored that possibility when I was at the University of Arizona and did a very small pilot on that. You know, acupuncture has an adaptative effect. It's very difficult to control whether you're going to be stimulating alertness or producing relaxation. It is extremely difficult, because it has to do with the state in which the person comes into the treatment, the amount of stimulation you provide, and the combination of points that you're using. I don't know that you could easily design a trial in that way and consciously produce opposite effects. In response to a statement made by an earlier questioner, there is truly a group that doesn't respond to acupuncture. We find that in our animal studies, and we find in our human studies that about 30% of people and animals simply do not respond to acupuncture. We have to take that into account. I think we know some of the mechanisms behind that, but I don't think that we know all of the mechanisms. Whether it's due to cholecystokinin or some other mechanism, I'm not sure, but that certainly is part of the process.
As a scientist, as a clinician, I find that one of the things that really puts off most of the Western allopathic community with regard to acupuncture, or any of the other areas of [complementary and alternative medicine] or [integrative] [CAM] or medicine, is the fact that we don't know much about how they work. So I would like to make the argument that it's as important for us to understand the mechanisms as well as anything else.
I also have concerns with regard to using imaging to study acupuncture. One of the difficulties has to do with the influence of acupuncture on the central nervous system. Acupuncture's effect there is as much a decrease in activity as it is an increase in activity. The release of opioids and the influence of GABA [␥-aminobutyric acid], which actually quiets down activity, is very important. But to look at this decrease in activity I think is much harder to do with the imaging studies. So I think we need to realize that's a limitation that the imaging studies will always have. Dr. Hammerschlag: I am aware of the reports of poor responders versus good responders for acupuncture analgesia and your allusion to the cholecystokinin system acting to counter endogenous opioid effects. There's certainly excellent evidence both in animals and humans for that phenomenon. There's also been some elegant rat work with molecular biological techniques of converting poor responders into good responders. One would love to have some acupuncture techniques that, in themselves, could convert poor responders into good responders. But my question for you is: In your acupuncture research on the cardiovascular system, do you see the same phenomena in animals and humans of poor responders and good responders?
Dr. Longhurst: You see exactly the same thing with our cardiovascular work, whether they're anesthetized or nonanesthetized, in humans and in animals.
Dr. Hammerschlag:
When we talk about acupuncture mechanism, we often think by analogy to the nervous system where we know, for example, what the receptor is that mediates a drug response. We also know the initial transduction event, and what the signal is. But we don't know with confidence what these analogous phenomena are for acupuncture. Although fMRI and other imaging studies are giving us remarkable insights of neural correlates of acupuncture, we don't really have a clear understanding of what happens between insertion of the needle and the brain activity that results in a functional MRI image. We don't know what the pathway is.
With a drug that has an effect on the immune system or endocrine system, we can measure changes in relevant biomarkers as well as correlated changes in brain function. We describe the results as an immune response or an endocrine response that the brain monitors. But with acupuncture, we seem to be assuming it is neurally mediated because we observe neural signals in the brain.
Vitaly Napadow, Ph.D., Lic.Ac.: Neuroimaging is not the "be-all and end-all" of physiological testing of acupuncture in animal or human models. It has its limitations just like any other technique. But it happens to be one of the best ways that we can study brain functions in humans. Some of the more invasive techniques that can be done in animals cannot be done in humans.
Having said that and taking the point made about deactivation to heart, there actually has been quite a series of studies that have been published showing deactivation in certain brain regions in response to acupuncture. All of very effective for pain relief. We have students who can use simple visualization and reduce the pain or completely eliminate the pain during qigong practice. The yi involves visualizing how the qi goes, where the stuck qi will go, where the good qi will be supplemented. That process can be achieved through qigong training, not just by acupuncture training.
Do we have any trials where you introduce the variable of intention as a scale or index to determine whether the therapist has the ability of visualization to make the pictures and change the pictures? If we can measure that, it will be very highly correlated with the result of clinical effect. Do you have any comments on this? Dr. Lao: As a researcher, I want to bring it back to the basis of research. All the practitioners have intention, whether they are practicing qigong, t'ui na, or acupuncture. So we have to answer the question: "How important is the intention itself on top of the intervention method?" How can we separate them? If the intention is very important, then the acupuncture needle may be less important. So we have to think of a more scientific basis to distinguish the physiologic component and the psychologic component. But I agree that for treatment, intention is an important part of what we provide to the patient. 
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